{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:18:56Z","timestamp":1794251936460,"version":"4.9.0"},"reference-count":217,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174296"],"award-info":[{"award-number":["82174296"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The gut\u2013liver\u2013kidney axis has emerged as a central regulatory network orchestrating metabolic, immune, and inflammatory homeostasis across organ systems. At its core lies the dynamic interplay between gut microbiota and host metabolism. Dysbiosis and impaired intestinal barrier integrity facilitate the systemic translocation of microbial metabolites\u2014such as short-chain fatty acids (SCFAs), bile acids (BAs), trimethylamine-N-oxide (TMAO), and tryptophan derivatives\u2014which profoundly influence hepatic lipid metabolism, renal immune responses, and overall metabolic balance. This review examines the molecular mechanisms through which gut-derived metabolites contribute to liver and kidney pathology, emphasizing inter-organ signaling and the pathological cascade of the \u201cleaky gut\u2013hepatic injury\u2013renal dysfunction\u201d loop. We critically evaluate emerging therapeutic strategies targeting this axis, including probiotic supplementation, fecal microbiota transplantation (FMT), dietary modulation (low-protein, high-fiber regimens), and pharmacological detoxification (e.g., AST\u2011120, molecular adsorbent recirculating systems [MARS]). Finally, we propose a conceptual \u201cdiet\u2013microbiota\u2013drug\u201d triad to guide precision interventions, and discuss current challenges such as interindividual variability, the lack of standardized assessment tools, and the need for integrative multi\u2011omics and clinical validation. A deeper mechanistic understanding of gut\u2013organ crosstalk may pave the way for innovative therapies to restore systemic metabolic homeostasis.<\/jats:p>","DOI":"10.1186\/s12964-025-02625-x","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T03:56:21Z","timestamp":1768362981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Targeting gut\u2013liver\u2013kidney axis: microbiota-derived metabolites and therapeutic implications"],"prefix":"10.1186","volume":"24","author":[{"given":"Yufei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"2625_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.metabol.2017.11.003","volume":"79","author":"A Mantovani","year":"2018","unstructured":"Mantovani A, Zaza G, Byrne CD, et al. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis. Metabolism. 2018;79:64\u201376. https:\/\/doi.org\/10.1016\/j.metabol.2017.11.003.","journal-title":"Metabolism"},{"key":"2625_CR2","doi-asserted-by":"publisher","first-page":"1365294","DOI":"10.3389\/fphar.2024.1365294","volume":"15","author":"Z Ming","year":"2024","unstructured":"Ming Z, Ruishi X, Linyi X, Yonggang Y, Haoming L, Xintian L. The gut-liver axis in fatty liver disease: role played by natural products. Front Pharmacol. 2024;15:1365294. https:\/\/doi.org\/10.3389\/fphar.2024.1365294.","journal-title":"Front Pharmacol"},{"key":"2625_CR3","doi-asserted-by":"publisher","unstructured":"Park JW, Kim SE, Lee NY, et al. Role of microbiota-derived metabolites in alcoholic and non-alcoholic fatty liver diseases. Int J Mol Sci. 2021;23(1).https:\/\/doi.org\/10.3390\/ijms23010426.","DOI":"10.3390\/ijms23010426"},{"key":"2625_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123072","volume":"357","author":"Y Tong","year":"2024","unstructured":"Tong Y, Guo S, Li T, et al. Gut microbiota and renal fibrosis. Life Sci. 2024;357:123072. https:\/\/doi.org\/10.1016\/j.lfs.2024.123072.","journal-title":"Life Sci"},{"key":"2625_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104617","volume":"152","author":"D Raj","year":"2020","unstructured":"Raj D, Tomar B, Lahiri A, Mulay SR. The gut-liver-kidney axis: novel regulator of fatty liver associated chronic kidney disease. Pharmacol Res. 2020;152:104617. https:\/\/doi.org\/10.1016\/j.phrs.2019.104617.","journal-title":"Pharmacol Res"},{"issue":"38","key":"2625_CR6","doi-asserted-by":"publisher","first-page":"15789","DOI":"10.1074\/jbc.M117.796516","volume":"292","author":"KT Bush","year":"2017","unstructured":"Bush KT, Wu W, Lun C, Nigam SK. The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut\u2013liver\u2013kidney axis. J Biol Chem. 2017;292(38):15789\u2013803. https:\/\/doi.org\/10.1074\/jbc.M117.796516.","journal-title":"J Biol Chem"},{"issue":"4","key":"2625_CR7","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","volume":"72","author":"CD Byrne","year":"2020","unstructured":"Byrne CD, Targher G. Nafld as a driver of chronic kidney disease. J Hepatol. 2020;72(4):785\u2013801. https:\/\/doi.org\/10.1016\/j.jhep.2020.01.013.","journal-title":"J Hepatol"},{"key":"2625_CR8","doi-asserted-by":"publisher","unstructured":"Pezzino S, Sofia M, Faletra G, et al. Gut-liver axis and non-alcoholic fatty liver disease: a vicious circle of dysfunctions orchestrated by the gut microbiome. Biology (Basel). 2022;11(11).https:\/\/doi.org\/10.3390\/biology11111622.","DOI":"10.3390\/biology11111622"},{"issue":"1","key":"2625_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-00830-x","volume":"30","author":"D Sun","year":"2024","unstructured":"Sun D, Xie C, Zhao Y, et al. The gut microbiota-bile acid axis in cholestatic liver disease. Mol Med. 2024;30(1):104. https:\/\/doi.org\/10.1186\/s10020-024-00830-x.","journal-title":"Mol Med"},{"issue":"1","key":"2625_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-024-01826-9","volume":"12","author":"X Zhou","year":"2024","unstructured":"Zhou X, Ji S, Chen L, et al. Gut microbiota dysbiosis in hyperuricaemia promotes renal injury through the activation of NLRP3 inflammasome. Microbiome. 2024;12(1):109. https:\/\/doi.org\/10.1186\/s40168-024-01826-9.","journal-title":"Microbiome"},{"key":"2625_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2025.115314","volume":"197","author":"Y Ye","year":"2025","unstructured":"Ye Y, Xu Y, Ji J, Zhang Y, Feng Y, Sun X. Polysaccharides extracted from Polygonatum sibiricum alleviate intestine-liver-kidney axis injury induced by citrinin and alcohol co-exposure in mice. Food Chem Toxicol. 2025;197:115314. https:\/\/doi.org\/10.1016\/j.fct.2025.115314.","journal-title":"Food Chem Toxicol"},{"issue":"14","key":"2625_CR12","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1042\/cs20160191","volume":"131","author":"J Jansen","year":"2017","unstructured":"Jansen J, Jankowski J, Gajjala PR, Wetzels JFM, Masereeuw R. Disposition and clinical implications of protein-bound uremic toxins. Clin Sci (Lond). 2017;131(14):1631\u201347. https:\/\/doi.org\/10.1042\/cs20160191.","journal-title":"Clin Sci (Lond)"},{"key":"2625_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2022.111618","volume":"548","author":"JYL Chiang","year":"2022","unstructured":"Chiang JYL, Ferrell JM. Discovery of farnesoid X receptor and its role in bile acid metabolism. Mol Cell Endocrinol. 2022;548:111618. https:\/\/doi.org\/10.1016\/j.mce.2022.111618.","journal-title":"Mol Cell Endocrinol"},{"key":"2625_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.861854","volume":"9","author":"W Zhu","year":"2022","unstructured":"Zhu W, Zhou Y, Tsao R, Dong H, Zhang H. Amelioratory effect of resistant starch on non-alcoholic fatty liver disease via the gut-liver axis. Front Nutr. 2022;9:861854. https:\/\/doi.org\/10.3389\/fnut.2022.861854.","journal-title":"Front Nutr"},{"issue":"1","key":"2625_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-024-03242-3","volume":"24","author":"T Li","year":"2024","unstructured":"Li T, Ma X, Wang T, et al. Clostridium butyricum inhibits the inflammation in children with primary nephrotic syndrome by regulating Th17\/Tregs balance via gut-kidney axis. BMC Microbiol. 2024;24(1):97. https:\/\/doi.org\/10.1186\/s12866-024-03242-3.","journal-title":"BMC Microbiol"},{"issue":"Suppl 1","key":"2625_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12072-017-9798-x","volume":"12","author":"JP Arab","year":"2018","unstructured":"Arab JP, Martin-Mateos RM, Shah VH. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg. Hepatol Int. 2018;12(Suppl 1):24\u201333. https:\/\/doi.org\/10.1007\/s12072-017-9798-x.","journal-title":"Hepatol Int"},{"issue":"3","key":"2625_CR17","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: pathophysiological basis for therapy. J Hepatol. 2020;72(3):558\u201377. https:\/\/doi.org\/10.1016\/j.jhep.2019.10.003.","journal-title":"J Hepatol"},{"key":"2625_CR18","doi-asserted-by":"publisher","unstructured":"Liu P, Zhang Y, Zhang Z, et al. Antibiotic-induced dysbiosis of the gut microbiota impairs gene expression in gut-liver axis of mice. Genes (Basel). 2023;14(7).https:\/\/doi.org\/10.3390\/genes14071423.","DOI":"10.3390\/genes14071423"},{"issue":"11","key":"2625_CR19","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nri2653","volume":"9","author":"JR Turner","year":"2009","unstructured":"Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9(11):799\u2013809. https:\/\/doi.org\/10.1038\/nri2653.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"2625_CR20","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1136\/gutjnl-2020-322260","volume":"69","author":"P Paone","year":"2020","unstructured":"Paone P, Cani PD. Mucus barrier, mucins and gut microbiota: the expected slimy partners? Gut. 2020;69(12):2232\u201343. https:\/\/doi.org\/10.1136\/gutjnl-2020-322260.","journal-title":"Gut"},{"key":"2625_CR21","doi-asserted-by":"publisher","unstructured":"Blesl A, Stadlbauer V. The gut-liver axis in cholestatic liver diseases. Nutrients. 2021;13(3). https:\/\/doi.org\/10.3390\/nu13031018.","DOI":"10.3390\/nu13031018"},{"issue":"6","key":"2625_CR22","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00535-017-1400-8","volume":"53","author":"T Inamine","year":"2018","unstructured":"Inamine T, Schnabl B. Immunoglobulin A and liver diseases. J Gastroenterol. 2018;53(6):691\u2013700. https:\/\/doi.org\/10.1007\/s00535-017-1400-8.","journal-title":"J Gastroenterol"},{"issue":"5","key":"2625_CR23","doi-asserted-by":"publisher","first-page":"E742","DOI":"10.1152\/ajpendo.00523.2019","volume":"318","author":"R El Hage","year":"2020","unstructured":"El Hage R, Hernandez-Sanabria E, Calatayud Arroyo M, Van de Wiele T. Supplementation of a propionate-producing consortium improves markers of insulin resistance in an in vitro model of gut-liver axis. Am J Physiol Endocrinol Metab. 2020;318(5):E742-e749. https:\/\/doi.org\/10.1152\/ajpendo.00523.2019.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2625_CR24","doi-asserted-by":"publisher","unstructured":"Mukhopadhya I, Louis P. Gut microbiota-derived short-chain fatty acids and their role in human health and disease. Nat Rev Microbiol. 2025.https:\/\/doi.org\/10.1038\/s41579-025-01183-w.","DOI":"10.1038\/s41579-025-01183-w"},{"issue":"3","key":"2625_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0396-1","volume":"9","author":"M Uittenbogaard","year":"2018","unstructured":"Uittenbogaard M, Brantner CA, Chiaramello A. Epigenetic modifiers promote mitochondrial biogenesis and oxidative metabolism leading to enhanced differentiation of neuroprogenitor cells. Cell Death Dis. 2018;9(3):360. https:\/\/doi.org\/10.1038\/s41419-018-0396-1.","journal-title":"Cell Death Dis"},{"issue":"4","key":"2625_CR26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1124\/dmd.121.000643","volume":"50","author":"S Choudhuri","year":"2022","unstructured":"Choudhuri S, Klaassen CD. Molecular regulation of bile acid homeostasis. Drug Metab Dispos. 2022;50(4):425\u201355. https:\/\/doi.org\/10.1124\/dmd.121.000643.","journal-title":"Drug Metab Dispos"},{"key":"2625_CR27","doi-asserted-by":"publisher","unstructured":"Bellanti F, Lo Buglio A, Vendemiale G. Hepatic mitochondria-gut microbiota interactions in metabolism-associated fatty liver disease. Metabolites. 2023;13(3). https:\/\/doi.org\/10.3390\/metabo13030322.","DOI":"10.3390\/metabo13030322"},{"issue":"1","key":"2625_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2232143","volume":"15","author":"B Han","year":"2023","unstructured":"Han B, Lv X, Liu G, et al. Gut microbiota-related bile acid metabolism-FXR\/TGR5 axis impacts the response to anti-\u03b14\u03b27-integrin therapy in humanized mice with colitis. Gut Microbes. 2023;15(1):2232143. https:\/\/doi.org\/10.1080\/19490976.2023.2232143.","journal-title":"Gut Microbes"},{"key":"2625_CR29","doi-asserted-by":"publisher","first-page":"1099935","DOI":"10.3389\/fphar.2023.1099935","volume":"14","author":"Y Dai","year":"2023","unstructured":"Dai Y, Jia Z, Fang C, et al. Polygoni Multiflori Radix interferes with bile acid metabolism homeostasis by inhibiting Fxr transcription, leading to cholestasis. Front Pharmacol. 2023;14:1099935. https:\/\/doi.org\/10.3389\/fphar.2023.1099935.","journal-title":"Front Pharmacol"},{"issue":"3","key":"2625_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1159\/000371668","volume":"33","author":"V Jourdainne","year":"2015","unstructured":"Jourdainne V, P\u00e9an N, Doignon I, Humbert L, Rainteau D, Tordjmann T. The bile acid receptor TGR5 and liver regeneration. Dig Dis. 2015;33(3):319\u201326. https:\/\/doi.org\/10.1159\/000371668.","journal-title":"Dig Dis"},{"issue":"4","key":"2625_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.livres.2017.12.004","volume":"1","author":"Z Zhou","year":"2017","unstructured":"Zhou Z, Zhong W. Targeting the gut barrier for the treatment of alcoholic liver disease. Liver Res. 2017;1(4):197\u2013207. https:\/\/doi.org\/10.1016\/j.livres.2017.12.004.","journal-title":"Liver Res"},{"issue":"3","key":"2625_CR32","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11605-021-05188-7","volume":"26","author":"L An","year":"2022","unstructured":"An L, Wirth U, Koch D, et al. The role of gut-derived lipopolysaccharides and the intestinal barrier in fatty liver diseases. J Gastrointest Surg. 2022;26(3):671\u201383. https:\/\/doi.org\/10.1007\/s11605-021-05188-7.","journal-title":"J Gastrointest Surg"},{"key":"2625_CR33","doi-asserted-by":"publisher","unstructured":"Sheng X, Wang L, Zhan P, He W, Tian H, Liu J. Thyme (Thymus quinquecostatus Celak) Polyphenol-Rich Extract (TPE) Alleviates HFD-Induced Liver Injury in Mice by Inactivating the TLR4\/NF-\u03baB signaling pathway through the gut-liver axis. Foods. 2023;12(16). https:\/\/doi.org\/10.3390\/foods12163074.","DOI":"10.3390\/foods12163074"},{"issue":"10","key":"2625_CR34","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1007\/s11695-007-9243-7","volume":"17","author":"AG Ruiz","year":"2007","unstructured":"Ruiz AG, Casafont F, Crespo J, et al. Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes Surg. 2007;17(10):1374\u201380. https:\/\/doi.org\/10.1007\/s11695-007-9243-7.","journal-title":"Obes Surg"},{"issue":"3","key":"2625_CR35","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/hep.28707","volume":"65","author":"AC Donepudi","year":"2017","unstructured":"Donepudi AC, Boehme S, Li F, Chiang JY. G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice. Hepatology. 2017;65(3):813\u201327. https:\/\/doi.org\/10.1002\/hep.28707.","journal-title":"Hepatology"},{"key":"2625_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fphar.2020.00012","volume":"11","author":"L Liu","year":"2020","unstructured":"Liu L, Liu Z, Li H, et al. Naturally occurring TPE-CA maintains gut microbiota and bile acids homeostasis via FXR signaling modulation of the liver-gut axis. Front Pharmacol. 2020;11:12. https:\/\/doi.org\/10.3389\/fphar.2020.00012.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2625_CR37","doi-asserted-by":"publisher","first-page":"e0357623","DOI":"10.1128\/spectrum.03576-23","volume":"12","author":"AS McMillan","year":"2024","unstructured":"McMillan AS, Foley MH, Perkins CE, Theriot CM. Loss of Bacteroides thetaiotaomicron bile acid-altering enzymes impacts bacterial fitness and the global metabolic transcriptome. Microbiol Spectr. 2024;12(1):e0357623. https:\/\/doi.org\/10.1128\/spectrum.03576-23.","journal-title":"Microbiol Spectr."},{"key":"2625_CR38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/bs.mie.2021.11.022","volume":"664","author":"A Sveistyte","year":"2022","unstructured":"Sveistyte A, Miller CJ, Brandvold KR, Wright AT. Bile salt hydrolase profiling by fluorogenic probes in the human gut microbiome. Methods Enzymol. 2022;664:243\u201365. https:\/\/doi.org\/10.1016\/bs.mie.2021.11.022.","journal-title":"Methods Enzymol"},{"key":"2625_CR39","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7659509","volume":"2019","author":"C Wang","year":"2019","unstructured":"Wang C, Zhu C, Shao L, Ye J, Shen Y, Ren Y. Role of bile acids in dysbiosis and treatment of nonalcoholic fatty liver disease. Mediators Inflamm. 2019;2019:7659509. https:\/\/doi.org\/10.1155\/2019\/7659509.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"2625_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.livres.2017.05.001","volume":"1","author":"JYL Chiang","year":"2017","unstructured":"Chiang JYL. Bile acid metabolism and signaling in liver disease and therapy. Liver Res. 2017;1(1):3\u20139. https:\/\/doi.org\/10.1016\/j.livres.2017.05.001.","journal-title":"Liver Res"},{"issue":"3","key":"2625_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101493","volume":"35","author":"R Li","year":"2021","unstructured":"Li R, Andreu-S\u00e1nchez S, Kuipers F, Fu J. Gut microbiome and bile acids in obesity-related diseases. Best Pract Res Clin Endocrinol Metab. 2021;35(3):101493. https:\/\/doi.org\/10.1016\/j.beem.2021.101493.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2625_CR42","doi-asserted-by":"publisher","unstructured":"Tsuji K, Uchida N, Nakanoh H, et al. The gut-kidney axis in chronic kidney diseases. Diagnostics (Basel). 2024;15(1). https:\/\/doi.org\/10.3390\/diagnostics15010021.","DOI":"10.3390\/diagnostics15010021"},{"issue":"4","key":"2625_CR43","doi-asserted-by":"publisher","first-page":"477","DOI":"10.18999\/nagjms.79.4.477","volume":"79","author":"M Yisireyili","year":"2017","unstructured":"Yisireyili M, Takeshita K, Saito S, Murohara T, Niwa T. Indole-3-propionic acid suppresses indoxyl sulfate-induced expression of fibrotic and inflammatory genes in proximal tubular cells. Nagoya J Med Sci. 2017;79(4):477\u201386. https:\/\/doi.org\/10.18999\/nagjms.79.4.477.","journal-title":"Nagoya J Med Sci"},{"key":"2625_CR44","doi-asserted-by":"publisher","first-page":"1182570","DOI":"10.3389\/fcell.2023.1182570","volume":"11","author":"YJ Li","year":"2023","unstructured":"Li YJ, Ma J, Loh YW, Chadban SJ, Wu H. Short-chain fatty acids directly exert anti-inflammatory responses in podocytes and tubular epithelial cells exposed to high glucose. Front Cell Dev Biol. 2023;11:1182570. https:\/\/doi.org\/10.3389\/fcell.2023.1182570.","journal-title":"Front Cell Dev Biol"},{"key":"2625_CR45","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3389\/fmicb.2018.01953","volume":"9","author":"J Wang","year":"2018","unstructured":"Wang J, Ji H, Wang S, et al. Probiotic Lactobacillus plantarum promotes intestinal barrier function by strengthening the epithelium and modulating gut microbiota. Front Microbiol. 2018;9:1953. https:\/\/doi.org\/10.3389\/fmicb.2018.01953.","journal-title":"Front Microbiol"},{"key":"2625_CR46","doi-asserted-by":"publisher","unstructured":"Cosola C, Rocchetti MT, di Bari I, et al. An innovative synbiotic formulation decreases free serum indoxyl sulfate, small intestine permeability and ameliorates gastrointestinal symptoms in a randomized pilot trial in stage IIIb-IV CKD patients. Toxins (Basel). 2021;13(5).https:\/\/doi.org\/10.3390\/toxins13050334.","DOI":"10.3390\/toxins13050334"},{"key":"2625_CR47","doi-asserted-by":"publisher","unstructured":"Tourountzis T, Lioulios G, Fylaktou A, Moysidou E, Papagianni A, Stangou M. Microbiome in chronic kidney disease. Life (Basel). 2022;12(10).https:\/\/doi.org\/10.3390\/life12101513.","DOI":"10.3390\/life12101513"},{"key":"2625_CR48","doi-asserted-by":"publisher","unstructured":"Liu WC, Tomino Y, Lu KC. Impacts of indoxyl sulfate and p-cresol sulfate on chronic kidney disease and mitigating effects of AST-120. Toxins (Basel). 2018;10(9). https:\/\/doi.org\/10.3390\/toxins10090367.","DOI":"10.3390\/toxins10090367"},{"key":"2625_CR49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.nut.2017.08.015","volume":"46","author":"D Mafra","year":"2018","unstructured":"Mafra D, Borges NA, Cardozo L, et al. Red meat intake in chronic kidney disease patients: two sides of the coin. Nutrition. 2018;46:26\u201332. https:\/\/doi.org\/10.1016\/j.nut.2017.08.015.","journal-title":"Nutrition"},{"issue":"6","key":"2625_CR50","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.26355\/eurrev_202203_28354","volume":"26","author":"A Noce","year":"2022","unstructured":"Noce A, Marchetti M, Marrone G, et al. Link between gut microbiota dysbiosis and chronic kidney disease. Eur Rev Med Pharmacol Sci. 2022;26(6):2057\u201374. https:\/\/doi.org\/10.26355\/eurrev_202203_28354.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"2625_CR51","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/jgh.13458","volume":"32","author":"CJ Grant","year":"2017","unstructured":"Grant CJ, Harrison LE, Hoad CL, Marciani L, Gowland PA, McIntyre CW. Patients with chronic kidney disease have abnormal upper gastro-intestinal tract digestive function: a study of uremic enteropathy. J Gastroenterol Hepatol. 2017;32(2):372\u20137. https:\/\/doi.org\/10.1111\/jgh.13458.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"2625_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-02865-0","volume":"11","author":"B Gao","year":"2021","unstructured":"Gao B, Jose A, Alonzo-Palma N, et al. Butyrate producing microbiota are reduced in chronic kidney diseases. Sci Rep. 2021;11(1):23530. https:\/\/doi.org\/10.1038\/s41598-021-02865-0.","journal-title":"Sci Rep"},{"issue":"4","key":"2625_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/mbo3.678","volume":"8","author":"H Lun","year":"2019","unstructured":"Lun H, Yang W, Zhao S, et al. Altered gut microbiota and microbial biomarkers associated with chronic kidney disease. Microbiologyopen. 2019;8(4):e00678. https:\/\/doi.org\/10.1002\/mbo3.678.","journal-title":"Microbiologyopen"},{"issue":"2","key":"2625_CR54","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1097\/imna-d-24-00044","volume":"12","author":"X Sun","year":"2025","unstructured":"Sun X, Xia C, Sun W, Sun S. Exploring enterotype characteristics of chronic kidney disease stages 3\u20135 based on the partitioning around medoids clustering algorithm. Integr Med Nephrol Androl. 2025;12(2):e24-00044. https:\/\/doi.org\/10.1097\/imna-d-24-00044.","journal-title":"Integr Med Nephrol Androl"},{"issue":"Pt 2","key":"2625_CR55","doi-asserted-by":"publisher","first-page":"113335","DOI":"10.1016\/j.intimp.2024.113335","volume":"143","author":"X Li","year":"2024","unstructured":"Li X, Li C, Wu P, Zhang L, Zhou P, Ma X. Recent status and trends of innate immunity and the gut-kidney aixs in IgAN: a systematic review and bibliometric analysis. Int Immunopharmacol. 2024;143(Pt 2):113335. https:\/\/doi.org\/10.1016\/j.intimp.2024.113335.","journal-title":"Int Immunopharmacol."},{"key":"2625_CR56","doi-asserted-by":"publisher","unstructured":"Kadatane SP, Satariano M, Massey M, Mongan K, Raina R. The role of inflammation in CKD. Cells. 2023;12(12).https:\/\/doi.org\/10.3390\/cells12121581.","DOI":"10.3390\/cells12121581"},{"key":"2625_CR57","doi-asserted-by":"publisher","unstructured":"Lonardo A, Mantovani A, Targher G, Baffy G. nonalcoholic fatty liver disease and chronic kidney disease: epidemiology, pathogenesis, and clinical and research implications. Int J Mol Sci.;23(21). https:\/\/doi.org\/10.3390\/ijms232113320.","DOI":"10.3390\/ijms232113320"},{"issue":"6","key":"2625_CR58","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.cmet.2019.03.014","volume":"29","author":"DA Cappel","year":"2019","unstructured":"Cappel DA, Deja S, Duarte JAG, et al. Pyruvate-carboxylase-mediated anaplerosis promotes antioxidant capacity by sustaining TCA cycle and redox metabolism in liver. Cell Metab. 2019;29(6):1291-1305.e8. https:\/\/doi.org\/10.1016\/j.cmet.2019.03.014.","journal-title":"Cell Metab"},{"issue":"6","key":"2625_CR59","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00467-016-3401-x","volume":"32","author":"ID Weiner","year":"2017","unstructured":"Weiner ID. Roles of renal ammonia metabolism other than in acid-base homeostasis. Pediatr Nephrol. 2017;32(6):933\u201342. https:\/\/doi.org\/10.1007\/s00467-016-3401-x.","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"2625_CR60","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/mnh.0000000000000255","volume":"25","author":"ID Weiner","year":"2016","unstructured":"Weiner ID, Verlander JW. Recent advances in understanding renal ammonia metabolism and transport. Curr Opin Nephrol Hypertens. 2016;25(5):436\u201343. https:\/\/doi.org\/10.1097\/mnh.0000000000000255.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"3","key":"2625_CR61","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3904\/kjim.2017.317","volume":"33","author":"KY Shim","year":"2018","unstructured":"Shim KY, Eom YW, Kim MY, Kang SH, Baik SK. Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension. Korean J Intern Med. 2018;33(3):453\u201361. https:\/\/doi.org\/10.3904\/kjim.2017.317.","journal-title":"Korean J Intern Med"},{"issue":"2","key":"2625_CR62","doi-asserted-by":"publisher","first-page":"H350","DOI":"10.1152\/ajpheart.00356.2017","volume":"314","author":"C Chollet","year":"2018","unstructured":"Chollet C, Placier S, Chatziantoniou C, et al. Genetically increased angiotensin I-converting enzyme alters peripheral and renal vascular reactivity to angiotensin II and bradykinin in mice. Am J Physiol Heart Circ Physiol. 2018;314(2):H350-h358. https:\/\/doi.org\/10.1152\/ajpheart.00356.2017.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"2625_CR63","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2478\/jtim-2022-0049","volume":"12","author":"H Zhao","year":"2024","unstructured":"Zhao H, Li Z, Yan M, et al. Irbesartan ameliorates diabetic kidney injury in db\/db mice by restoring circadian rhythm and cell cycle. J Transl Intern Med. 2024;12(2):157\u201369. https:\/\/doi.org\/10.2478\/jtim-2022-0049.","journal-title":"J Transl Intern Med"},{"issue":"1","key":"2625_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-25738-6","volume":"12","author":"H Gao","year":"2022","unstructured":"Gao H, Wang X, Ma H, et al. LncRNA CCAT2, involving miR-34a\/TGF-\u03b21\/Smad4 signaling, regulate hepatic stellate cells proliferation. Sci Rep. 2022;12(1):21199. https:\/\/doi.org\/10.1038\/s41598-022-25738-6.","journal-title":"Sci Rep"},{"issue":"5","key":"2625_CR65","first-page":"578","volume":"50","author":"C Li","year":"2020","unstructured":"Li C, Xiao Q, Gu C, Zhao Y, Liu L, Wang H. Hepatocyte growth factor inhibits renal angiotensin II expression in 5\/6 nephrectomized rats. Ann Clin Lab Sci. 2020;50(5):578\u201383.","journal-title":"Ann Clin Lab Sci"},{"key":"2625_CR66","doi-asserted-by":"publisher","unstructured":"Fialla AD, Schaffalitzky de Muckadell OB, Bie P, Thiesson HC. Activation of RAAS in a rat model of liver cirrhosis: no effect of losartan on renal sodium excretion. BMC Nephrol. 2018;19(1):238. https:\/\/doi.org\/10.1186\/s12882-018-1039-6.","DOI":"10.1186\/s12882-018-1039-6"},{"key":"2625_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112513","volume":"138","author":"X Zuo","year":"2024","unstructured":"Zuo X, Gao L, Peng X, et al. Unveiling the role of mtDNA in Liver-Kidney crosstalk: insights from trichloroethylene hypersensitivity syndrome. Int Immunopharmacol. 2024;138:112513. https:\/\/doi.org\/10.1016\/j.intimp.2024.112513.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"2625_CR68","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1080\/03007995.2024.2358242","volume":"40","author":"L Peluso","year":"2024","unstructured":"Peluso L, Savi M, Coppalini G, et al. Management of hepatorenal syndrome and treatment-related adverse events. Curr Med Res Opin. 2024;40(7):1155\u201362. https:\/\/doi.org\/10.1080\/03007995.2024.2358242.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"2625_CR69","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/hep.30513","volume":"70","author":"JM Ferrell","year":"2019","unstructured":"Ferrell JM, Pathak P, Boehme S, Gilliland T, Chiang JYL. Deficiency of both farnesoid X receptor and Takeda G protein-coupled receptor 5 exacerbated liver fibrosis in mice. Hepatology. 2019;70(3):955\u201370. https:\/\/doi.org\/10.1002\/hep.30513.","journal-title":"Hepatology"},{"issue":"1","key":"2625_CR70","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/mnh.0000000000000374","volume":"27","author":"M Herman-Edelstein","year":"2018","unstructured":"Herman-Edelstein M, Weinstein T, Levi M. Bile acid receptors and the kidney. Curr Opin Nephrol Hypertens. 2018;27(1):56\u201362. https:\/\/doi.org\/10.1097\/mnh.0000000000000374.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2625_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.673708","volume":"12","author":"Y Kinashi","year":"2021","unstructured":"Kinashi Y, Hase K. Partners in leaky gut syndrome: intestinal dysbiosis and autoimmunity. Front Immunol. 2021;12:673708. https:\/\/doi.org\/10.3389\/fimmu.2021.673708.","journal-title":"Front Immunol"},{"issue":"13","key":"2625_CR72","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.7150\/ijms.100963","volume":"21","author":"CM Zheng","year":"2024","unstructured":"Zheng CM, Hou YC, Tsai KW, et al. Resveratrol mitigates uremic toxin-induced intestinal barrier dysfunction in chronic kidney disease by promoting mitophagy and inhibiting apoptosis pathways. Int J Med Sci. 2024;21(13):2437\u201349. https:\/\/doi.org\/10.7150\/ijms.100963.","journal-title":"Int J Med Sci"},{"issue":"3","key":"2625_CR73","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1159\/000493292","volume":"49","author":"Z Weng","year":"2018","unstructured":"Weng Z, Chi Y, Xie J, et al. Anti-inflammatory activity of dehydroandrographolide by TLR4\/NF-\u03baB Signaling Pathway Inhibition in Bile Duct-Ligated Mice. Cell Physiol Biochem. 2018;49(3):1083\u201396. https:\/\/doi.org\/10.1159\/000493292.","journal-title":"Cell Physiol Biochem"},{"key":"2625_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106472","volume":"83","author":"X Zhou","year":"2020","unstructured":"Zhou X, Jiang K, Luo H, Wu C, Yu W, Cheng F. Novel lncRNA XLOC_032768 alleviates cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells through TNF-\u03b1. Int Immunopharmacol. 2020;83:106472. https:\/\/doi.org\/10.1016\/j.intimp.2020.106472.","journal-title":"Int Immunopharmacol"},{"key":"2625_CR75","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbrc.2022.09.075","volume":"634","author":"J Li","year":"2022","unstructured":"Li J, Liu X, Wu Y, Ji W, Tian Q, Li S. Aerobic exercise improves intestinal mucosal barrier dysfunction through TLR4\/MyD88\/NF-\u03baB signaling pathway in diabetic rats. Biochem Biophys Res Commun. 2022;634:75\u201382. https:\/\/doi.org\/10.1016\/j.bbrc.2022.09.075.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2625_CR76","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s12020-022-03002-1","volume":"76","author":"K Cai","year":"2022","unstructured":"Cai K, Ma Y, Cai F, et al. Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury. Endocrine. 2022;76(2):294\u2013303. https:\/\/doi.org\/10.1007\/s12020-022-03002-1.","journal-title":"Endocrine"},{"key":"2625_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2024.115420","volume":"199","author":"M Saban G\u00fcler","year":"2025","unstructured":"Saban G\u00fcler M, Arslan S, A\u011fag\u00fcnd\u00fcz D, et al. Butyrate: a potential mediator of obesity and microbiome via different mechanisms of actions. Food Res Int. 2025;199:115420. https:\/\/doi.org\/10.1016\/j.foodres.2024.115420.","journal-title":"Food Res Int"},{"issue":"7","key":"2625_CR78","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.2337\/db14-1213","volume":"64","author":"G den Besten","year":"2015","unstructured":"den Besten G, Bleeker A, Gerding A, et al. Short-chain fatty acids protect against high-fat diet\u2013induced obesity via a PPAR\u03b3-dependent switch from lipogenesis to fat oxidation. Diabetes. 2015;64(7):2398\u2013408. https:\/\/doi.org\/10.2337\/db14-1213.","journal-title":"Diabetes"},{"issue":"1","key":"2625_CR79","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1139\/bcb-2022-0314","volume":"101","author":"Y Chen","year":"2023","unstructured":"Chen Y, Cai K, Du Y, Liu Z, Gong Y. HDAC1 overexpression promoted by METTL3-IGF2BP2 inhibits FGF21 expression in metabolic syndrome-related liver injury. Biochem Cell Biol. 2023;101(1):52\u201363. https:\/\/doi.org\/10.1139\/bcb-2022-0314.","journal-title":"Biochem Cell Biol"},{"issue":"3","key":"2625_CR80","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1042\/cs20210470","volume":"136","author":"Z Zheng","year":"2022","unstructured":"Zheng Z, Zhang S, Chen J, et al. The HDAC2\/SP1\/miR-205 feedback loop contributes to tubular epithelial cell extracellular matrix production in diabetic kidney disease. Clin Sci Lond. 2022;136(3):223\u201338. https:\/\/doi.org\/10.1042\/cs20210470.","journal-title":"Clin Sci Lond"},{"key":"2625_CR81","doi-asserted-by":"publisher","unstructured":"Fusco W, Lorenzo MB, Cintoni M, et al. Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota. Nutrients. 2023;15(9).https:\/\/doi.org\/10.3390\/nu15092211.","DOI":"10.3390\/nu15092211"},{"issue":"1","key":"2625_CR82","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2393270","volume":"16","author":"KE Hays","year":"2024","unstructured":"Hays KE, Pfaffinger JM, Ryznar R. The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease. Gut Microbes. 2024;16(1):2393270. https:\/\/doi.org\/10.1080\/19490976.2024.2393270.","journal-title":"Gut Microbes"},{"issue":"1","key":"2625_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-00237-6","volume":"15","author":"T Dissayabutra","year":"2025","unstructured":"Dissayabutra T, Chuaypen N, Somnark P, et al. Characterization of gut dysbiosis and intestinal barrier dysfunction in patients with metabolic dysfunction-associated steatotic liver disease and chronic kidney disease: a comparative study. Sci Rep. 2025;15(1):15481. https:\/\/doi.org\/10.1038\/s41598-025-00237-6.","journal-title":"Sci Rep"},{"issue":"10","key":"2625_CR84","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.ajpath.2023.06.007","volume":"193","author":"K Pant","year":"2023","unstructured":"Pant K, Venugopal SK, Lorenzo Pisarello MJ, Gradilone SA. The role of gut microbiome-derived short-chain fatty acid butyrate in hepatobiliary diseases. Am J Pathol. 2023;193(10):1455\u201367. https:\/\/doi.org\/10.1016\/j.ajpath.2023.06.007.","journal-title":"Am J Pathol"},{"key":"2625_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117997","volume":"256","author":"Z Xiao","year":"2020","unstructured":"Xiao Z, Chu Y, Qin W. IGFBP5 modulates lipid metabolism and insulin sensitivity through activating AMPK pathway in non-alcoholic fatty liver disease. Life Sci. 2020;256:117997. https:\/\/doi.org\/10.1016\/j.lfs.2020.117997.","journal-title":"Life Sci"},{"key":"2625_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156537","volume":"139","author":"W Zeng","year":"2025","unstructured":"Zeng W, Sun M, Cao J, et al. Triterpenoids from ilicis rotundae cortex ameliorate hyperlipidemia by affecting bile acids-hepatointestinal FXR axis. Phytomedicine. 2025;139:156537. https:\/\/doi.org\/10.1016\/j.phymed.2025.156537.","journal-title":"Phytomedicine"},{"key":"2625_CR87","doi-asserted-by":"publisher","unstructured":"Wang H, Wu K, Mi X, Rajput SA, Qi D. Effects of 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors on cholesterol metabolism in laying hens. Animals (Basel). Jun 3 2023;13(11).https:\/\/doi.org\/10.3390\/ani13111868.","DOI":"10.3390\/ani13111868"},{"issue":"12","key":"2625_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0316362","volume":"19","author":"L Liu","year":"2024","unstructured":"Liu L, Chen T, Xie Z, Zhang Y, He C, Huang Y. Butyric acid alleviates LPS-induced intestinal mucosal barrier damage by inhibiting the RhoA\/ROCK2\/MLCK signaling pathway in Caco2 cells. PLoS One. 2024;19(12):e0316362. https:\/\/doi.org\/10.1371\/journal.pone.0316362.","journal-title":"PLoS One"},{"issue":"5","key":"2625_CR89","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.3168\/jds.2021-21198","volume":"105","author":"X Wang","year":"2022","unstructured":"Wang X, Zhu M, Loor JJ, et al. Propionate alleviates fatty acid-induced mitochondrial dysfunction, oxidative stress, and apoptosis by upregulating PPARG coactivator 1 alpha in hepatocytes. J Dairy Sci. 2022;105(5):4581\u201392. https:\/\/doi.org\/10.3168\/jds.2021-21198.","journal-title":"J Dairy Sci"},{"issue":"3","key":"2625_CR90","doi-asserted-by":"publisher","first-page":"e20192195","DOI":"10.1084\/jem.20192195","volume":"217","author":"M Keir","year":"2020","unstructured":"Keir M, Yi Y, Lu T, Ghilardi N. The role of IL-22 in intestinal health and disease. J Exp Med. 2020;217(3):e20192195. https:\/\/doi.org\/10.1084\/jem.20192195.","journal-title":"J Exp Med."},{"issue":"1","key":"2625_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18262-6","volume":"11","author":"W Yang","year":"2020","unstructured":"Yang W, Yu T, Huang X, et al. Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat Commun. 2020;11(1):4457. https:\/\/doi.org\/10.1038\/s41467-020-18262-6.","journal-title":"Nat Commun"},{"issue":"5","key":"2625_CR92","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.immuni.2019.09.014","volume":"51","author":"E Chun","year":"2019","unstructured":"Chun E, Lavoie S, Fonseca-Pereira D, et al. Metabolite-sensing receptor Ffar2 regulates colonic group 3 innate lymphoid cells and gut immunity. Immunity. 2019;51(5):871-884.e6. https:\/\/doi.org\/10.1016\/j.immuni.2019.09.014.","journal-title":"Immunity"},{"issue":"3","key":"2625_CR93","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101371R","volume":"36","author":"M Jin","year":"2022","unstructured":"Jin M, Zhang H, Wu M, et al. Colonic interleukin-22 protects intestinal mucosal barrier and microbiota abundance in severe acute pancreatitis. FASEB J. 2022;36(3):e22174. https:\/\/doi.org\/10.1096\/fj.202101371R.","journal-title":"FASEB J"},{"key":"2625_CR94","doi-asserted-by":"publisher","unstructured":"Budau R, Okamura T, Hasegawa Y, Nakanishi N, Hamaguchi M, Fukui M. Supplementation of Miso to a Western-type diet stimulates ILC3s and decreases inflammation in the small intestine. Nutrients. 2024;16(21).https:\/\/doi.org\/10.3390\/nu16213743.","DOI":"10.3390\/nu16213743"},{"issue":"10","key":"2625_CR95","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1097\/cm9.0000000000000228","volume":"132","author":"LZ Li","year":"2019","unstructured":"Li LZ, Tao SB, Ma L, Fu P. Roles of short-chain fatty acids in kidney diseases. Chin Med J (Engl). 2019;132(10):1228\u201332. https:\/\/doi.org\/10.1097\/cm9.0000000000000228.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"2625_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-017-0300-8","volume":"5","author":"Q Mu","year":"2017","unstructured":"Mu Q, Zhang H, Liao X, et al. Control of lupus nephritis by changes of gut microbiota. Microbiome. 2017;5(1):73. https:\/\/doi.org\/10.1186\/s40168-017-0300-8.","journal-title":"Microbiome"},{"issue":"11","key":"2625_CR97","doi-asserted-by":"publisher","first-page":"11894","DOI":"10.1096\/fj.201901080R","volume":"33","author":"RJF Felizardo","year":"2019","unstructured":"Felizardo RJF, de Almeida DC, Pereira RL, et al. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms. FASEB J. 2019;33(11):11894\u2013908. https:\/\/doi.org\/10.1096\/fj.201901080R.","journal-title":"FASEB J"},{"key":"2625_CR98","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4074832","volume":"2020","author":"W Huang","year":"2020","unstructured":"Huang W, Man Y, Gao C, et al. Short-chain fatty acids ameliorate diabetic nephropathy via GPR43-mediated inhibition of oxidative stress and NF-\u03baB signaling. Oxid Med Cell Longev. 2020;2020:4074832. https:\/\/doi.org\/10.1155\/2020\/4074832.","journal-title":"Oxid Med Cell Longev"},{"key":"2625_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116203","volume":"224","author":"C Favero","year":"2024","unstructured":"Favero C, Pintor-Chocano A, Sanz A, Ortiz A, Sanchez-Ni\u00f1o MD. Butyrate promotes kidney resilience through a coordinated kidney protective response in tubular cells. Biochem Pharmacol. 2024;224:116203. https:\/\/doi.org\/10.1016\/j.bcp.2024.116203.","journal-title":"Biochem Pharmacol"},{"key":"2625_CR100","doi-asserted-by":"publisher","unstructured":"Nicese MN, Bijkerk R, Van Zonneveld AJ, Van den Berg BM, Rotmans JI. Sodium butyrate as key regulator of mitochondrial function and barrier integrity of human glomerular endothelial cells. Int J Mol Sci. 2023;24(17). https:\/\/doi.org\/10.3390\/ijms241713090.","DOI":"10.3390\/ijms241713090"},{"issue":"2","key":"2625_CR101","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1097\/imna-d-24-00068","volume":"12","author":"Y Zou","year":"2025","unstructured":"Zou Y, Guo X, Liu S. Metabolites mediate the causal associations between gut microbiota and chronic kidney disease: a Mendelian randomization study and therapeutical strategy from traditional Chinese medicine perspective. Integr Med Nephrol Androl. 2025;12(2):e24-00068. https:\/\/doi.org\/10.1097\/imna-d-24-00068.","journal-title":"Integr Med Nephrol Androl"},{"key":"2625_CR102","doi-asserted-by":"publisher","unstructured":"Xia J, Zhang Y, Zhang S, Lu C, Huan H, Guan X. Oat dietary fiber delays the progression of chronic kidney disease in mice by modulating the gut microbiota and reducing uremic toxin levels. J Agric Food Chem. 2024.https:\/\/doi.org\/10.1021\/acs.jafc.4c02591.","DOI":"10.1021\/acs.jafc.4c02591"},{"issue":"1","key":"2625_CR103","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/ndt\/gfae118","volume":"40","author":"V Corte-Iglesias","year":"2024","unstructured":"Corte-Iglesias V, Saiz ML, Andrade-Lopez AC, et al. Propionate and butyrate counteract renal damage and progression to chronic kidney disease. Nephrol Dial Transplant. 2024;40(1):133\u201350. https:\/\/doi.org\/10.1093\/ndt\/gfae118.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2625_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-68227-8","volume":"14","author":"K Ye","year":"2024","unstructured":"Ye K, Zhao Y, Huang W, Zhu Y. Sodium butyrate improves renal injury in diabetic nephropathy through AMPK\/SIRT1\/PGC-1\u03b1 signaling pathway. Sci Rep. 2024;14(1):17867. https:\/\/doi.org\/10.1038\/s41598-024-68227-8.","journal-title":"Sci Rep"},{"key":"2625_CR105","doi-asserted-by":"publisher","unstructured":"Tayyeb JZ, Popeijus HE, Mensink RP, Plat J. Butyric acid added apically to intestinal Caco-2 Cells elevates hepatic ApoA-I transcription and rescues lower ApoA-I expression in inflamed HepG2 cells co-cultured in the basolateral compartment. Biomolecules. 2021;11(1).https:\/\/doi.org\/10.3390\/biom11010071.","DOI":"10.3390\/biom11010071"},{"issue":"9","key":"2625_CR106","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.34067\/kid.0000292021","volume":"2","author":"O Foresto-Neto","year":"2021","unstructured":"Foresto-Neto O, Ghirotto B, C\u00e2mara NOS. Renal sensing of bacterial metabolites in the gut-kidney axis. Kidney360. 2021;2(9):1501\u20139. https:\/\/doi.org\/10.34067\/kid.0000292021.","journal-title":"Kidney360"},{"issue":"2","key":"2625_CR107","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.bbrc.2017.03.071","volume":"486","author":"M Kobayashi","year":"2017","unstructured":"Kobayashi M, Mikami D, Kimura H, et al. Short-chain fatty acids, GPR41 and GPR43 ligands, inhibit TNF-\u03b1-induced MCP-1 expression by modulating p38 and JNK signaling pathways in human renal cortical epithelial cells. Biochem Biophys Res Commun. 2017;486(2):499\u2013505. https:\/\/doi.org\/10.1016\/j.bbrc.2017.03.071.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2625_CR108","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.4049\/jimmunol.1502046","volume":"196","author":"J Park","year":"2016","unstructured":"Park J, Goergen CJ, HogenEsch H, Kim CH. Chronically elevated levels of short-chain fatty acids induce T cell-mediated ureteritis and hydronephrosis. J Immunol. 2016;196(5):2388\u2013400. https:\/\/doi.org\/10.4049\/jimmunol.1502046.","journal-title":"J Immunol"},{"key":"2625_CR109","doi-asserted-by":"publisher","unstructured":"Shi Q, Yuan X, Zeng Y, et al. Crosstalk between gut microbiota and bile acids in cholestatic liver disease. Nutrients. 2023;15(10).https:\/\/doi.org\/10.3390\/nu15102411.","DOI":"10.3390\/nu15102411"},{"issue":"1","key":"2625_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-021-01101-1","volume":"9","author":"DV Guzior","year":"2021","unstructured":"Guzior DV, Quinn RA. Review: microbial transformations of human bile acids. Microbiome. 2021;9(1):140. https:\/\/doi.org\/10.1186\/s40168-021-01101-1.","journal-title":"Microbiome"},{"issue":"5","key":"2625_CR111","doi-asserted-by":"publisher","first-page":"669","DOI":"10.4161\/19490976.2014.969986","volume":"5","author":"SA Joyce","year":"2014","unstructured":"Joyce SA, Shanahan F, Hill C, Gahan CG. Bacterial bile salt hydrolase in host metabolism: potential for influencing gastrointestinal microbe-host crosstalk. Gut Microbes. 2014;5(5):669\u201374. https:\/\/doi.org\/10.4161\/19490976.2014.969986.","journal-title":"Gut Microbes"},{"key":"2625_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2024.127865","volume":"287","author":"B Wang","year":"2024","unstructured":"Wang B, Han D, Hu X, Chen J, Liu Y, Wu J. Exploring the role of a novel postbiotic bile acid: interplay with gut microbiota, modulation of the farnesoid X receptor, and prospects for clinical translation. Microbiol Res. 2024;287:127865. https:\/\/doi.org\/10.1016\/j.micres.2024.127865.","journal-title":"Microbiol Res"},{"issue":"10","key":"2625_CR113","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1194\/jlr.M069807","volume":"57","author":"H Liu","year":"2016","unstructured":"Liu H, Pathak P, Boehme S, Chiang JL. Cholesterol 7\u03b1-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis. J Lipid Res. 2016;57(10):1831\u201344. https:\/\/doi.org\/10.1194\/jlr.M069807.","journal-title":"J Lipid Res"},{"issue":"2","key":"2625_CR114","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1530\/joe-17-0557","volume":"238","author":"P Comeglio","year":"2018","unstructured":"Comeglio P, Cellai I, Mello T, et al. INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function. J Endocrinol. 2018;238(2):107\u201327. https:\/\/doi.org\/10.1530\/joe-17-0557.","journal-title":"J Endocrinol"},{"issue":"4","key":"2625_CR115","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/hep.29857","volume":"68","author":"P Pathak","year":"2018","unstructured":"Pathak P, Xie C, Nichols RG, et al. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism. Hepatology. 2018;68(4):1574\u201388. https:\/\/doi.org\/10.1002\/hep.29857.","journal-title":"Hepatology"},{"key":"2625_CR116","doi-asserted-by":"publisher","unstructured":"Zhu L, Fang S, Zhang H, et al. Total Sn-2 palmitic triacylglycerols and the ratio of OPL to OPO in human milk fat substitute modulated bile acid metabolism and intestinal microbiota composition in rats. Nutrients. 2023;15(23). https:\/\/doi.org\/10.3390\/nu15234929.","DOI":"10.3390\/nu15234929"},{"issue":"4","key":"2625_CR117","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/hep.24525","volume":"54","author":"YD Wang","year":"2011","unstructured":"Wang YD, Chen WD, Yu D, Forman BM, Huang W. The G-Protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-\u03baB) in mice. Hepatology. 2011;54(4):1421\u201332. https:\/\/doi.org\/10.1002\/hep.24525.","journal-title":"Hepatology"},{"issue":"1","key":"2625_CR118","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s13311-017-0588-x","volume":"15","author":"SN Freedman","year":"2018","unstructured":"Freedman SN, Shahi SK, Mangalam AK. The \u201cGut Feeling\u201d: breaking down the role of gut microbiome in multiple sclerosis. Neurotherapeutics. 2018;15(1):109\u201325. https:\/\/doi.org\/10.1007\/s13311-017-0588-x.","journal-title":"Neurotherapeutics"},{"issue":"2","key":"2625_CR119","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jhep.2023.10.035","volume":"80","author":"A Ghallab","year":"2024","unstructured":"Ghallab A, Gonz\u00e1lez D, Str\u00e4ngberg E, et al. Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis. J Hepatol. 2024;80(2):268\u201381. https:\/\/doi.org\/10.1016\/j.jhep.2023.10.035.","journal-title":"J Hepatol"},{"issue":"11","key":"2625_CR120","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1016\/j.ekir.2024.08.002","volume":"9","author":"Y Fang","year":"2024","unstructured":"Fang Y, Qin M, Zheng Q, et al. Role of bile acid receptors in the development and function of diabetic nephropathy. Kidney Int Rep. 2024;9(11):3116\u201333. https:\/\/doi.org\/10.1016\/j.ekir.2024.08.002.","journal-title":"Kidney Int Rep"},{"key":"2625_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2020.152458","volume":"438","author":"M Hoshi","year":"2020","unstructured":"Hoshi M, Osawa Y, Nakamoto K, et al. Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice. Toxicology. 2020;438:152458. https:\/\/doi.org\/10.1016\/j.tox.2020.152458.","journal-title":"Toxicology"},{"issue":"8","key":"2625_CR122","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1038\/s41564-024-01737-3","volume":"9","author":"AK Sinha","year":"2024","unstructured":"Sinha AK, Laursen MF, Brinck JE, et al. Dietary fibre directs microbial tryptophan metabolism via metabolic interactions in the gut microbiota. Nat Microbiol. 2024;9(8):1964\u201378. https:\/\/doi.org\/10.1038\/s41564-024-01737-3.","journal-title":"Nat Microbiol"},{"key":"2625_CR123","doi-asserted-by":"publisher","unstructured":"Tan Q, Deng S, Xiong L. Role of kynurenine and its derivatives in liver diseases: recent advances and future clinical perspectives. Int J Mol Sci. 2025;26(3).https:\/\/doi.org\/10.3390\/ijms26030968.","DOI":"10.3390\/ijms26030968"},{"issue":"1","key":"2625_CR124","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00726-022-03123-x","volume":"54","author":"NP Hyland","year":"2022","unstructured":"Hyland NP, Cavanaugh CR, Hornby PJ. Emerging effects of tryptophan pathway metabolites and intestinal microbiota on metabolism and intestinal function. Amino Acids. 2022;54(1):57\u201370. https:\/\/doi.org\/10.1007\/s00726-022-03123-x.","journal-title":"Amino Acids"},{"issue":"1","key":"2625_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/nu15010151","volume":"15","author":"H Jiang","year":"2022","unstructured":"Jiang H, Chen C, Gao J. Extensive summary of the important roles of Indole propionic acid, a gut microbial metabolite in host health and disease. Nutrients. 2022;15(1):151. https:\/\/doi.org\/10.3390\/nu15010151.","journal-title":"Nutrients"},{"key":"2625_CR126","doi-asserted-by":"publisher","unstructured":"Cheng TH, Ma MC, Liao MT, et al. Indoxyl sulfate, a tubular toxin, contributes to the development of chronic kidney disease. Toxins (Basel). 2020;12(11).https:\/\/doi.org\/10.3390\/toxins12110684.","DOI":"10.3390\/toxins12110684"},{"issue":"1","key":"2625_CR127","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2307568","volume":"16","author":"BH Min","year":"2024","unstructured":"Min BH, Devi S, Kwon GH, et al. Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation. Gut Microbes. 2024;16(1):2307568. https:\/\/doi.org\/10.1080\/19490976.2024.2307568.","journal-title":"Gut Microbes"},{"issue":"2","key":"2625_CR128","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/fcp.12842","volume":"37","author":"SE Owumi","year":"2023","unstructured":"Owumi SE, Arunsi UO, Oyelere AK. The protective effect of 3-indolepropanoic acid on aflatoxin B1-induced systemic perturbation of the liver and kidney function in rats. Fundam Clin Pharmacol. 2023;37(2):369\u201384. https:\/\/doi.org\/10.1111\/fcp.12842.","journal-title":"Fundam Clin Pharmacol"},{"issue":"48","key":"2625_CR129","doi-asserted-by":"publisher","first-page":"26746","DOI":"10.1021\/acs.jafc.4c07716","volume":"72","author":"Q Wang","year":"2024","unstructured":"Wang Q, Liang J, Zou Q, et al. Tryptophan metabolism-regulating probiotics alleviate hyperuricemia by protecting the gut barrier integrity and enhancing colonic uric acid excretion. J Agric Food Chem. 2024;72(48):26746\u201361. https:\/\/doi.org\/10.1021\/acs.jafc.4c07716.","journal-title":"J Agric Food Chem"},{"key":"2625_CR130","doi-asserted-by":"publisher","unstructured":"Fang Z, Pan T, Wang H, et al. Limosilactobacillus reuteri Attenuates atopic dermatitis via changes in gut bacteria and indole derivatives from tryptophan metabolism. Int J Mol Sci. 2022;23(14).https:\/\/doi.org\/10.3390\/ijms23147735.","DOI":"10.3390\/ijms23147735"},{"issue":"6510","key":"2625_CR131","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1126\/science.abb3763","volume":"369","author":"L Lobel","year":"2020","unstructured":"Lobel L, Cao YG, Fenn K, Glickman JN, Garrett WS. Diet posttranslationally modifies the mouse gut microbial proteome to modulate renal function. Science. 2020;369(6510):1518\u201324. https:\/\/doi.org\/10.1126\/science.abb3763.","journal-title":"Science"},{"issue":"5","key":"2625_CR132","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202200432","volume":"67","author":"L Mervant","year":"2023","unstructured":"Mervant L, Tremblay-Franco M, Olier M, et al. Urinary metabolome analysis reveals potential microbiota alteration and electrophilic burden induced by high red meat diet: results from the french nutrinet-sant\u00e9 cohort and an in vivo intervention study in rats. Mol Nutr Food Res. 2023;67(5):e2200432. https:\/\/doi.org\/10.1002\/mnfr.202200432.","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"2625_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-025-08016-9","volume":"8","author":"D Lei","year":"2025","unstructured":"Lei D, Liu Y, Liu Y, et al. The gut microbiota metabolite trimethylamine N-oxide promotes cardiac hypertrophy by activating the autophagic degradation of SERCA2a. Commun Biol. 2025;8(1):596. https:\/\/doi.org\/10.1038\/s42003-025-08016-9.","journal-title":"Commun Biol"},{"issue":"8","key":"2625_CR134","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161074","volume":"11","author":"C Robinson-Cohen","year":"2016","unstructured":"Robinson-Cohen C, Newitt R, Shen DD, et al. Association of FMO3 variants and trimethylamine N-oxide concentration, disease progression, and mortality in CKD patients. PLoS One. 2016;11(8):e0161074. https:\/\/doi.org\/10.1371\/journal.pone.0161074.","journal-title":"PLoS One"},{"issue":"7","key":"2625_CR135","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/eurheartj\/ehy799","volume":"40","author":"Z Wang","year":"2019","unstructured":"Wang Z, Bergeron N, Levison BS, et al. Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women. Eur Heart J. 2019;40(7):583\u201394. https:\/\/doi.org\/10.1093\/eurheartj\/ehy799.","journal-title":"Eur Heart J"},{"key":"2625_CR136","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.733507","volume":"8","author":"X Li","year":"2021","unstructured":"Li X, Hong J, Wang Y, Pei M, Wang L, Gong Z. Trimethylamine-N-oxide pathway: a potential target for the treatment of MAFLD. Front Mol Biosci. 2021;8:733507. https:\/\/doi.org\/10.3389\/fmolb.2021.733507.","journal-title":"Front Mol Biosci"},{"issue":"17","key":"2625_CR137","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201900257","volume":"63","author":"X Tan","year":"2019","unstructured":"Tan X, Liu Y, Long J, et al. Trimethylamine N-oxide aggravates liver steatosis through modulation of bile acid metabolism and inhibition of farnesoid X receptor signaling in nonalcoholic fatty liver disease. Mol Nutr Food Res. 2019;63(17):e1900257. https:\/\/doi.org\/10.1002\/mnfr.201900257.","journal-title":"Mol Nutr Food Res"},{"issue":"28","key":"2625_CR138","doi-asserted-by":"publisher","first-page":"7869","DOI":"10.1021\/acs.jafc.9b03092","volume":"67","author":"PY Chen","year":"2019","unstructured":"Chen PY, Li S, Koh YC, et al. Oolong tea extract and citrus peel polymethoxyflavones reduce transformation of l-carnitine to trimethylamine-N-oxide and decrease vascular inflammation in l-carnitine feeding mice. J Agric Food Chem. 2019;67(28):7869\u201379. https:\/\/doi.org\/10.1021\/acs.jafc.9b03092.","journal-title":"J Agric Food Chem"},{"issue":"1","key":"2625_CR139","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01387-y","volume":"7","author":"KY Xu","year":"2017","unstructured":"Xu KY, Xia GH, Lu JQ, et al. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients. Sci Rep. 2017;7(1):1445. https:\/\/doi.org\/10.1038\/s41598-017-01387-y.","journal-title":"Sci Rep"},{"issue":"1","key":"2625_CR140","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-025-13481-7","volume":"109","author":"J Jiang","year":"2025","unstructured":"Jiang J, Zhu P, Ding X, et al. The microbiome-derived metabolite trimethylamine N-oxide is associated with chronic kidney disease risk. Appl Microbiol Biotechnol. 2025;109(1):97. https:\/\/doi.org\/10.1007\/s00253-025-13481-7.","journal-title":"Appl Microbiol Biotechnol"},{"key":"2625_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.682482","volume":"12","author":"Q Fang","year":"2021","unstructured":"Fang Q, Zheng B, Liu N, et al. Trimethylamine n-oxide exacerbates renal inflammation and fibrosis in rats with diabetic kidney disease. Front Physiol. 2021;12:682482. https:\/\/doi.org\/10.3389\/fphys.2021.682482.","journal-title":"Front Physiol"},{"issue":"1","key":"2625_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-023-00745-z","volume":"29","author":"L Ma","year":"2023","unstructured":"Ma L, Zhang L, Li J, et al. The potential mechanism of gut microbiota-microbial metabolites-mitochondrial axis in progression of diabetic kidney disease. Mol Med. 2023;29(1):148. https:\/\/doi.org\/10.1186\/s10020-023-00745-z.","journal-title":"Mol Med"},{"issue":"1","key":"2625_CR143","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-00895-8","volume":"30","author":"JW Jang","year":"2024","unstructured":"Jang JW, Capaldi E, Smith T, Verma P, Varga J, Ho KJ. Trimethylamine N-oxide: a meta-organismal axis linking the gut and fibrosis. Mol Med. 2024;30(1):128. https:\/\/doi.org\/10.1186\/s10020-024-00895-8.","journal-title":"Mol Med"},{"key":"2625_CR144","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.nutres.2022.04.001","volume":"104","author":"MA Cantero","year":"2022","unstructured":"Cantero MA, Guedes MRA, Fernandes R, Lollo PCB. Trimethylamine N-oxide reduction is related to probiotic strain specificity: a systematic review. Nutr Res. 2022;104:29\u201335. https:\/\/doi.org\/10.1016\/j.nutres.2022.04.001.","journal-title":"Nutr Res"},{"key":"2625_CR145","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4634172","volume":"2020","author":"Y Liu","year":"2020","unstructured":"Liu Y, Dai M. Trimethylamine n-oxide generated by the gut microbiota is associated with vascular inflammation: new insights into atherosclerosis. Mediators Inflamm. 2020;2020:4634172. https:\/\/doi.org\/10.1155\/2020\/4634172.","journal-title":"Mediators Inflamm"},{"key":"2625_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153829","volume":"98","author":"J Cui","year":"2022","unstructured":"Cui J, Shi Y, Xu X, Zhao F, Zhang J, Wei B. Identifying the cardioprotective mechanism of Danyu Tongmai Granules against myocardial infarction by targeted metabolomics combined with network pharmacology. Phytomedicine. 2022;98:153829. https:\/\/doi.org\/10.1016\/j.phymed.2021.153829.","journal-title":"Phytomedicine"},{"issue":"6","key":"2625_CR147","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1136\/gutjnl-2020-323071","volume":"70","author":"A Agus","year":"2021","unstructured":"Agus A, Cl\u00e9ment K, Sokol H. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut. 2021;70(6):1174\u201382. https:\/\/doi.org\/10.1136\/gutjnl-2020-323071.","journal-title":"Gut"},{"key":"2625_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155111","volume":"121","author":"J Qiu","year":"2023","unstructured":"Qiu J, Chen L, Zhang L, et al. Xie zhuo tiao zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy. Phytomedicine. 2023;121:155111. https:\/\/doi.org\/10.1016\/j.phymed.2023.155111.","journal-title":"Phytomedicine"},{"issue":"Feb","key":"2625_CR149","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13856","volume":"26","author":"S Mansoori","year":"2025","unstructured":"Mansoori S, Ho MY, Ng KK, Cheng KK. Branched-chain amino acid metabolism: pathophysiological mechanism and therapeutic intervention in metabolic diseases. Obes Rev. 2025;26(Feb):e13856. https:\/\/doi.org\/10.1111\/obr.13856.","journal-title":"Obes Rev"},{"issue":"6","key":"2625_CR150","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.clnu.2022.03.027","volume":"41","author":"G Konstantis","year":"2022","unstructured":"Konstantis G, Pourzitaki C, Chourdakis M, Kitsikidou E, Germanidis G. Efficacy of branched chain amino acids supplementation in liver cirrhosis: a systematic review and meta-analysis. Clin Nutr. 2022;41(6):1171\u201390. https:\/\/doi.org\/10.1016\/j.clnu.2022.03.027.","journal-title":"Clin Nutr"},{"issue":"2","key":"2625_CR151","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.bbrc.2015.09.017","volume":"466","author":"N Mi","year":"2015","unstructured":"Mi N, Zhang XJ, Ding Y, et al. Branched-chain amino acids attenuate early kidney injury in diabetic rats. Biochem Biophys Res Commun. 2015;466(2):240\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2015.09.017.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2625_CR152","doi-asserted-by":"publisher","first-page":"F152","DOI":"10.1152\/ajprenal.00260.2024","volume":"328","author":"S DiMartino","year":"2025","unstructured":"DiMartino S, Revelo MP, Mallipattu SK, Piret SE. Activation of branched chain amino acid catabolism protects against nephrotoxic acute kidney injury. Am J Physiol Renal Physiol. 2025;328(1):F152-f163. https:\/\/doi.org\/10.1152\/ajprenal.00260.2024.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"2625_CR153","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cmet.2021.03.025","volume":"33","author":"D Yu","year":"2021","unstructured":"Yu D, Richardson NE, Green CL, et al. The adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine. Cell Metab. 2021;33(5):905-922.e6. https:\/\/doi.org\/10.1016\/j.cmet.2021.03.025.","journal-title":"Cell Metab"},{"key":"2625_CR154","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jsbmb.2016.07.014","volume":"173","author":"TD Thacher","year":"2017","unstructured":"Thacher TD, Levine MA. CYP2R1 mutations causing vitamin D-deficiency rickets. J Steroid Biochem Mol Biol. 2017;173:333\u20136. https:\/\/doi.org\/10.1016\/j.jsbmb.2016.07.014.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"2625_CR155","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.semnephrol.2012.12.016","volume":"33","author":"C Bosworth","year":"2013","unstructured":"Bosworth C, de Boer IH. Impaired vitamin D metabolism in CKD. Semin Nephrol. 2013;33(2):158\u201368. https:\/\/doi.org\/10.1016\/j.semnephrol.2012.12.016.","journal-title":"Semin Nephrol"},{"key":"2625_CR156","doi-asserted-by":"publisher","unstructured":"Fuchs MA, Grabner A, Shi M, et al. Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice. J Clin Invest. 2024;135(4).https:\/\/doi.org\/10.1172\/jci179882.","DOI":"10.1172\/jci179882"},{"issue":"4","key":"2625_CR157","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/14728222.2019.1586883","volume":"23","author":"D Pawlak","year":"2019","unstructured":"Pawlak D, Domaniewski T, Znorko B, Pawlak K. The use of LP533401 as a therapeutic option for renal osteodystrophy affects, renal calcium handling, vitamin D metabolism, and bone health in uremic rats. Expert Opin Ther Targets. 2019;23(4):353\u201364. https:\/\/doi.org\/10.1080\/14728222.2019.1586883.","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"2625_CR158","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-024-00911-x","volume":"23","author":"S Ebrahimpour-Koujan","year":"2024","unstructured":"Ebrahimpour-Koujan S, Sohrabpour AA, Giovannucci E, Vatannejad A, Esmaillzadeh A. Effects of vitamin D supplementation on liver fibrogenic factors, vitamin D receptor and liver fibrogenic microRNAs in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: an exploratory randomized clinical trial. Nutr J. 2024;23(1):24. https:\/\/doi.org\/10.1186\/s12937-024-00911-x.","journal-title":"Nutr J"},{"key":"2625_CR159","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.biopha.2018.10.140","volume":"109","author":"W Udomsinprasert","year":"2019","unstructured":"Udomsinprasert W, Jittikoon J. Vitamin D and liver fibrosis: molecular mechanisms and clinical studies. Biomed Pharmacother. 2019;109:1351\u201360. https:\/\/doi.org\/10.1016\/j.biopha.2018.10.140.","journal-title":"Biomed Pharmacother"},{"key":"2625_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/bonekey.2013.232","volume":"3","author":"SU Nigwekar","year":"2014","unstructured":"Nigwekar SU, Tamez H, Thadhani RI. Vitamin D and chronic kidney disease-mineral bone disease (CKD-MBD). BoneKEy Rep. 2014;3:498. https:\/\/doi.org\/10.1038\/bonekey.2013.232.","journal-title":"BoneKEy Rep"},{"issue":"7","key":"2625_CR161","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41430-021-01065-3","volume":"76","author":"X Yang","year":"2022","unstructured":"Yang X, Zhu Q, Zhang L, et al. Causal relationship between gut microbiota and serum vitamin D: evidence from genetic correlation and Mendelian randomization study. Eur J Clin Nutr. 2022;76(7):1017\u201323. https:\/\/doi.org\/10.1038\/s41430-021-01065-3.","journal-title":"Eur J Clin Nutr"},{"issue":"5","key":"2625_CR162","doi-asserted-by":"publisher","first-page":"G341","DOI":"10.1152\/ajpgi.00105.2015","volume":"309","author":"S Wu","year":"2015","unstructured":"Wu S, Yoon S, Zhang YG, et al. Vitamin D receptor pathway is required for probiotic protection in colitis. Am J Physiol Gastrointest Liver Physiol. 2015;309(5):G341\u20139. https:\/\/doi.org\/10.1152\/ajpgi.00105.2015.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2625_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122001","volume":"331","author":"J Wei","year":"2023","unstructured":"Wei J, Li Z, Fan Y, et al. Lactobacillus rhamnosus GG aggravates vascular calcification in chronic kidney disease: a potential role for extracellular vesicles. Life Sci. 2023;331:122001. https:\/\/doi.org\/10.1016\/j.lfs.2023.122001.","journal-title":"Life Sci"},{"key":"2625_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2023.109450","volume":"122","author":"A Shibamoto","year":"2023","unstructured":"Shibamoto A, Kaji K, Nishimura N, et al. Vitamin D deficiency exacerbates alcohol-related liver injury via gut barrier disruption and hepatic overload of endotoxin. J Nutr Biochem. 2023;122:109450. https:\/\/doi.org\/10.1016\/j.jnutbio.2023.109450.","journal-title":"J Nutr Biochem"},{"issue":"6","key":"2625_CR165","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1002\/hep.30652","volume":"73","author":"YE Cho","year":"2021","unstructured":"Cho YE, Kim DK, Seo W, Gao B, Yoo SH, Song BJ. Fructose promotes leaky gut, endotoxemia, and liver fibrosis through ethanol-inducible cytochrome P450\u20132E1-mediated oxidative and nitrative stress. Hepatology. 2021;73(6):2180\u201395. https:\/\/doi.org\/10.1002\/hep.30652.","journal-title":"Hepatology"},{"issue":"12","key":"2625_CR166","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1016\/j.cmet.2021.09.004","volume":"33","author":"MA Febbraio","year":"2021","unstructured":"Febbraio MA, Karin M. Sweet death\": Fructose as a metabolic toxin that targets the gut-liver axis. Cell Metab. 2021;33(12):2316\u201328. https:\/\/doi.org\/10.1016\/j.cmet.2021.09.004.","journal-title":"Cell Metab"},{"issue":"5","key":"2625_CR167","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/mco.0000000000000853","volume":"25","author":"E Koene","year":"2022","unstructured":"Koene E, Schrauwen-Hinderling VB, Schrauwen P, Brouwers M. Novel insights in intestinal and hepatic fructose metabolism: from mice to men. Curr Opin Clin Nutr Metab Care. 2022;25(5):354\u20139. https:\/\/doi.org\/10.1097\/mco.0000000000000853.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2625_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2024.109635","volume":"129","author":"S Deng","year":"2024","unstructured":"Deng S, Ge Y, Zhai Z, et al. Fructose induces hepatic steatosis in adolescent mice linked to the disorders of lipid metabolism, bile acid metabolism, and autophagy. J Nutr Biochem. 2024;129:109635. https:\/\/doi.org\/10.1016\/j.jnutbio.2024.109635.","journal-title":"J Nutr Biochem"},{"issue":"2","key":"2625_CR169","doi-asserted-by":"publisher","first-page":"e0469822","DOI":"10.1128\/spectrum.04698-22","volume":"11","author":"J Yu","year":"2023","unstructured":"Yu J, Liu T, Guo Q, Wang Z, Chen Y, Dong Y. Disruption of the intestinal mucosal barrier induced by high fructose and restraint stress is regulated by the intestinal microbiota and microbiota metabolites. Microbiol Spectr. 2023;11(2):e0469822. https:\/\/doi.org\/10.1128\/spectrum.04698-22.","journal-title":"Microbiol Spectr."},{"key":"2625_CR170","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bcp.2019.05.016","volume":"166","author":"TS Li","year":"2019","unstructured":"Li TS, Chen L, Wang SC, et al. Magnesium isoglycyrrhizinate ameliorates fructose-induced podocyte apoptosis through downregulation of miR-193a to increase WT1. Biochem Pharmacol. 2019;166:139\u201352. https:\/\/doi.org\/10.1016\/j.bcp.2019.05.016.","journal-title":"Biochem Pharmacol"},{"issue":"16","key":"2625_CR171","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202400191","volume":"68","author":"N Pengrattanachot","year":"2024","unstructured":"Pengrattanachot N, Thongnak L, Promsan S, et al. Fructooligosaccharides ameliorate renal injury and dysfunction through the modulation of gut dysbiosis, inhibition of renal inflammation, oxidative stress, fibrosis, and improve organic anion transporter 3 function in an obese rat model. Mol Nutr Food Res. 2024;68(16):e2400191. https:\/\/doi.org\/10.1002\/mnfr.202400191.","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"2625_CR172","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01913-1","volume":"9","author":"H Miao","year":"2024","unstructured":"Miao H, Liu F, Wang YN, et al. Targeting Lactobacillus johnsonii to reverse chronic kidney disease. Signal Transduct Target Ther. 2024;9(1):195. https:\/\/doi.org\/10.1038\/s41392-024-01913-1.","journal-title":"Signal Transduct Target Ther"},{"key":"2625_CR173","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1358063","volume":"14","author":"SY Xiong","year":"2024","unstructured":"Xiong SY, Wu GS, Li C, Ma W, Luo HR. Clinical efficacy of probiotics in the treatment of alcoholic liver disease: a systematic review and meta-analysis. Front Cell Infect Microbiol. 2024;14:1358063. https:\/\/doi.org\/10.3389\/fcimb.2024.1358063.","journal-title":"Front Cell Infect Microbiol"},{"key":"2625_CR174","doi-asserted-by":"publisher","unstructured":"Hizo GH, Rampelotto PH. The impact of probiotic bifidobacterium on liver diseases and the microbiota. Life (Basel). 2024;14(2).https:\/\/doi.org\/10.3390\/life14020239.","DOI":"10.3390\/life14020239"},{"key":"2625_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115434","volume":"166","author":"J Wang","year":"2023","unstructured":"Wang J, Guo X, Zou Z, et al. Ootheca mantidis mitigates renal fibrosis in mice by the suppression of apoptosis via increasing the gut microbe Akkermansia muciniphila and modulating glutamine metabolism. Biomed Pharmacother. 2023;166:115434. https:\/\/doi.org\/10.1016\/j.biopha.2023.115434.","journal-title":"Biomed Pharmacother"},{"key":"2625_CR176","doi-asserted-by":"publisher","first-page":"1037257","DOI":"10.3389\/fmicb.2022.1037257","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, Zhang M, Wang X, et al. Fecal microbiota transplantation restores normal fecal composition and delays malignant development of mild chronic kidney disease in rats. Front Microbiol. 2022;13:1037257. https:\/\/doi.org\/10.3389\/fmicb.2022.1037257.","journal-title":"Front Microbiol"},{"key":"2625_CR177","doi-asserted-by":"publisher","unstructured":"Arteaga-Muller GY, Flores-Trevi\u00f1o S, Bocanegra-Ibarias P, et al. Changes in the progression of chronic kidney disease in patients undergoing fecal microbiota transplantation. Nutrients. 2024;16(8). https:\/\/doi.org\/10.3390\/nu16081109.","DOI":"10.3390\/nu16081109"},{"issue":"4","key":"2625_CR178","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1055\/s-0041-1732319","volume":"41","author":"X Gu","year":"2021","unstructured":"Gu X, Lu Q, Zhang C, Tang Z, Chu L. Clinical application and progress of fecal microbiota transplantation in liver diseases: a review. Semin Liver Dis. 2021;41(4):495\u2013506. https:\/\/doi.org\/10.1055\/s-0041-1732319.","journal-title":"Semin Liver Dis"},{"key":"2625_CR179","doi-asserted-by":"publisher","unstructured":"Boicean A, Birlutiu V, Ichim C, Brusnic O, Oni\u0219or DM. Fecal microbiota transplantation in liver cirrhosis. Biomedicines. 2023;11(11).https:\/\/doi.org\/10.3390\/biomedicines11112930.","DOI":"10.3390\/biomedicines11112930"},{"issue":"6","key":"2625_CR180","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/hep.29306","volume":"66","author":"JS Bajaj","year":"2017","unstructured":"Bajaj JS, Kassam Z, Fagan A, et al. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial. Hepatology. 2017;66(6):1727\u201338. https:\/\/doi.org\/10.1002\/hep.29306.","journal-title":"Hepatology"},{"issue":"1","key":"2625_CR181","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/mco.0000000000000342","volume":"20","author":"GJ Ko","year":"2017","unstructured":"Ko GJ, Obi Y, Tortorici AR, Kalantar-Zadeh K. Dietary protein intake and chronic kidney disease. Curr Opin Clin Nutr Metab Care. 2017;20(1):77\u201385. https:\/\/doi.org\/10.1097\/mco.0000000000000342.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"8","key":"2625_CR182","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1007\/s40620-024-02065-9","volume":"37","author":"CH Chen","year":"2024","unstructured":"Chen CH, Tsai PH, Tsai WC, et al. Efficacy and safety of ketoanalogue supplementation combined with protein-restricted diets in advanced chronic kidney disease: a systematic review and meta-analysis. J Nephrol. 2024;37(8):2113\u201325. https:\/\/doi.org\/10.1007\/s40620-024-02065-9.","journal-title":"J Nephrol"},{"key":"2625_CR183","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01057","volume":"9","author":"J Chen","year":"2018","unstructured":"Chen J, Kang B, Jiang Q, et al. Alpha-ketoglutarate in low-protein diets for growing pigs: effects on cecal microbial communities and parameters of microbial metabolism. Front Microbiol. 2018;9:1057. https:\/\/doi.org\/10.3389\/fmicb.2018.01057.","journal-title":"Front Microbiol"},{"issue":"4","key":"2625_CR184","first-page":"819","volume":"40","author":"L Chang","year":"2023","unstructured":"Chang L, Tian R, Guo Z, et al. Low-protein diet supplemented with inulin lowers protein-bound toxin levels in patients with stage 3b\u20135 chronic kidney disease: a randomized controlled study. Nutr Hosp. 2023;40(4):819\u201328 (La dieta baja en prote\u00ednas suplementada con inulina reduce los niveles de toxinas unidas a prote\u00ednas en pacientes con enfermedad renal cr\u00f3nica en estadio 3b-5: un estudio controlado aleatorio 10.20960\/nh.04643IF: 1.1 Q4 B4).","journal-title":"Nutr Hosp"},{"issue":"18","key":"2625_CR185","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.3748\/wjg.v27.i18.2160","volume":"27","author":"S Takayama","year":"2021","unstructured":"Takayama S, Katada K, Takagi T, et al. Partially hydrolyzed guar gum attenuates non-alcoholic fatty liver disease in mice through the gut-liver axis. World J Gastroenterol. 2021;27(18):2160\u201376. https:\/\/doi.org\/10.3748\/wjg.v27.i18.2160.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2625_CR186","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/0886022x.2018.1561376","volume":"41","author":"M Asai","year":"2019","unstructured":"Asai M, Kumakura S, Kikuchi M. Review of the efficacy of AST-120 (KREMEZIN(\u00ae)) on renal function in chronic kidney disease patients. Ren Fail. 2019;41(1):47\u201356. https:\/\/doi.org\/10.1080\/0886022x.2018.1561376.","journal-title":"Ren Fail"},{"issue":"1","key":"2625_CR187","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04165-z","volume":"26","author":"C Monet","year":"2022","unstructured":"Monet C, De Jong A, Aarab Y, et al. Adverse events, short- and long-term outcomes of extra corporeal liver therapy in the intensive care unit: 16 years experience with MARS\u00ae in a single center. Crit Care. 2022;26(1):282. https:\/\/doi.org\/10.1186\/s13054-022-04165-z.","journal-title":"Crit Care"},{"issue":"2","key":"2625_CR188","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/ccm.0000000000005194","volume":"50","author":"AJ MacDonald","year":"2022","unstructured":"MacDonald AJ, Subramanian RM, Olson JC, et al. Use of the molecular adsorbent recirculating system in acute liver failure: results of a multicenter propensity score-matched study. Crit Care Med. 2022;50(2):286\u201395. https:\/\/doi.org\/10.1097\/ccm.0000000000005194.","journal-title":"Crit Care Med"},{"issue":"3","key":"2625_CR189","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/circresaha.116.305360","volume":"116","author":"WH Tang","year":"2015","unstructured":"Tang WH, Wang Z, Kennedy DJ, et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res. 2015;116(3):448\u201355. https:\/\/doi.org\/10.1161\/circresaha.116.305360.","journal-title":"Circ Res"},{"key":"2625_CR190","doi-asserted-by":"publisher","DOI":"10.1038\/srep19076","volume":"6","author":"YM Chen","year":"2016","unstructured":"Chen YM, Liu Y, Zhou RF, et al. Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults. Sci Rep. 2016;6:19076. https:\/\/doi.org\/10.1038\/srep19076.","journal-title":"Sci Rep"},{"key":"2625_CR191","doi-asserted-by":"publisher","unstructured":"Fu J, Zheng Y, Gao Y, Xu W. Dietary fiber intake and gut microbiota in human health. Microorganisms. 2022;10(12).https:\/\/doi.org\/10.3390\/microorganisms10122507.","DOI":"10.3390\/microorganisms10122507"},{"key":"2625_CR192","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2020.593735","volume":"7","author":"H Zhao","year":"2020","unstructured":"Zhao H, Yang A, Mao L, Quan Y, Cui J, Sun Y. Association between dietary fiber intake and non-alcoholic fatty liver disease in adults. Front Nutr. 2020;7:593735. https:\/\/doi.org\/10.3389\/fnut.2020.593735.","journal-title":"Front Nutr"},{"issue":"5","key":"2625_CR193","doi-asserted-by":"publisher","DOI":"10.1111\/cts.70229","volume":"18","author":"T Capozza","year":"2025","unstructured":"Capozza T, Burkey J, Van De Wetering J, et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of INT-787, a novel farnesoid X receptor agonist, in healthy volunteers: a phase 1 trial. Clin Transl Sci. 2025;18(5):e70229. https:\/\/doi.org\/10.1111\/cts.70229.","journal-title":"Clin Transl Sci"},{"issue":"1","key":"2625_CR194","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-06718-0","volume":"7","author":"J Wang","year":"2024","unstructured":"Wang J, Wang W, Zhang J, et al. Deficiency of flavin-containing monooxygenase 3 protects kidney function after ischemia-reperfusion in mice. Commun Biol. 2024;7(1):1054. https:\/\/doi.org\/10.1038\/s42003-024-06718-0.","journal-title":"Commun Biol"},{"issue":"2","key":"2625_CR195","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s12602-024-10365-6","volume":"17","author":"S Noor","year":"2025","unstructured":"Noor S, Ali S, Summer M, Riaz A, Nazakat L, Aqsa. Therapeutic role of probiotics against environmental-induced hepatotoxicity: mechanisms, clinical perspectives, limitations, and future. Probiotics Antimicrob Proteins. 2025;17(2):516\u201340. https:\/\/doi.org\/10.1007\/s12602-024-10365-6.","journal-title":"Probiotics Antimicrob Proteins."},{"issue":"1","key":"2625_CR196","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2025.2480749","volume":"47","author":"Y Wang","year":"2025","unstructured":"Wang Y, Chen Y, Xiao Z, Shi Y, Fu C, Cao Y. Fecal microbiota transplantation modulates myeloid-derived suppressor cells and attenuates renal fibrosis in a murine model. Ren Fail. 2025;47(1):2480749. https:\/\/doi.org\/10.1080\/0886022x.2025.2480749.","journal-title":"Ren Fail"},{"issue":"5","key":"2625_CR197","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202406445","volume":"12","author":"J Xiao","year":"2025","unstructured":"Xiao J, Hou Y, Luo X, et al. Clostridium scindens protects against vancomycin-induced cholestasis and liver fibrosis by activating intestinal FXR-FGF15\/19 signaling. Adv Sci (Weinh). 2025;12(5):e2406445. https:\/\/doi.org\/10.1002\/advs.202406445.","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"2625_CR198","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1124\/jpet.120.000285","volume":"376","author":"TR Casta\u00f1eda","year":"2021","unstructured":"Casta\u00f1eda TR, M\u00e9ndez M, Davison I, et al. The novel phosphate and bile acid sequestrant polymer SAR442357 delays disease progression in a rat model of diabetic nephropathy. J Pharmacol Exp Ther. 2021;376(2):190\u2013203. https:\/\/doi.org\/10.1124\/jpet.120.000285.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2625_CR199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1897212","volume":"13","author":"A Nogal","year":"2021","unstructured":"Nogal A, Valdes AM, Menni C. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut Microbes. 2021;13(1):1\u201324. https:\/\/doi.org\/10.1080\/19490976.2021.1897212.","journal-title":"Gut Microbes."},{"issue":"11","key":"2625_CR200","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1016\/j.cmet.2024.10.001","volume":"36","author":"Y Liao","year":"2024","unstructured":"Liao Y, Chen Q, Liu L, et al. Amino acid is a major carbon source for hepatic lipogenesis. Cell Metab. 2024;36(11):2437-2448.e8. https:\/\/doi.org\/10.1016\/j.cmet.2024.10.001.","journal-title":"Cell Metab"},{"issue":"8","key":"2625_CR201","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1080\/10408398.2016.1245650","volume":"58","author":"J Hu","year":"2018","unstructured":"Hu J, Lin S, Zheng B, Cheung PCK. Short-chain fatty acids in control of energy metabolism. Crit Rev Food Sci Nutr. 2018;58(8):1243\u20139. https:\/\/doi.org\/10.1080\/10408398.2016.1245650.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"2625_CR202","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ijbiomac.2019.12.169","volume":"145","author":"ES Lee","year":"2020","unstructured":"Lee ES, Song EJ, Nam YD, et al. Effects of enzymatically modified chestnut starch on the gut microbiome, microbial metabolome, and transcriptome of diet-induced obese mice. Int J Biol Macromol. 2020;145:235\u201343. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.12.169.","journal-title":"Int J Biol Macromol"},{"key":"2625_CR203","doi-asserted-by":"publisher","unstructured":"Pauly MJ, Rohde JK, John C, et al. Inulin supplementation disturbs hepatic cholesterol and bile acid metabolism independent from housing temperature. Nutrients. 2020;12(10). https:\/\/doi.org\/10.3390\/nu12103200.","DOI":"10.3390\/nu12103200"},{"issue":"23","key":"2625_CR204","doi-asserted-by":"publisher","first-page":"11432","DOI":"10.1039\/d4fo03353a","volume":"15","author":"F Zeng","year":"2024","unstructured":"Zeng F, He S, Sun Y, et al. Abnormal enterohepatic circulation of bile acids caused by fructooligosaccharide supplementation along with a high-fat diet. Food Funct. 2024;15(23):11432\u201343. https:\/\/doi.org\/10.1039\/d4fo03353a.","journal-title":"Food Funct"},{"issue":"1","key":"2625_CR205","doi-asserted-by":"publisher","DOI":"10.1097\/imna-d-24-00006","volume":"11","author":"A Brendolan","year":"2024","unstructured":"Brendolan A, Lorenzin A, De Cal M, et al. Hemoadsorption combined with hemodialysis and the \u201cInflammation Mitigation Hypothesis.\u201d Integr Med Nephrol Androl. 2024;11(1):e00006. https:\/\/doi.org\/10.1097\/imna-d-24-00006.","journal-title":"Integr Med Nephrol Androl"},{"key":"2625_CR206","doi-asserted-by":"publisher","DOI":"10.12659\/msm.923805","volume":"26","author":"G Kade","year":"2020","unstructured":"Kade G, Lubas A, Spaleniak S, et al. Application of the molecular adsorbent recirculating system in type 1 hepatorenal syndrome in the course of alcohol-related acute on chronic liver failure. Med Sci Monit. 2020;26:e923805. https:\/\/doi.org\/10.12659\/msm.923805.","journal-title":"Med Sci Monit"},{"issue":"5","key":"2625_CR207","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s10157-018-1577-z","volume":"22","author":"A Yoshifuji","year":"2018","unstructured":"Yoshifuji A, Wakino S, Irie J, et al. Oral adsorbent AST-120 ameliorates gut environment and protects against the progression of renal impairment in CKD rats. Clin Exp Nephrol. 2018;22(5):1069\u201378. https:\/\/doi.org\/10.1007\/s10157-018-1577-z.","journal-title":"Clin Exp Nephrol"},{"issue":"10","key":"2625_CR208","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1097\/ccm.0000000000002562","volume":"45","author":"HU Gerth","year":"2017","unstructured":"Gerth HU, Pohlen M, Th\u00f6lking G, et al. Molecular adsorbent recirculating system can reduce short-term mortality among patients with acute-on-chronic liver failure-a retrospective analysis. Crit Care Med. 2017;45(10):1616\u201324. https:\/\/doi.org\/10.1097\/ccm.0000000000002562.","journal-title":"Crit Care Med"},{"key":"2625_CR209","doi-asserted-by":"publisher","unstructured":"Kapetanaki S, Kumawat AK, Persson K, Demirel I. The Fibrotic Effects of TMAO on Human Renal Fibroblasts Is Mediated by NLRP3, Caspase-1 and the PERK\/Akt\/mTOR Pathway. Int J Mol Sci. Nov 1 2021;22(21).https:\/\/doi.org\/10.3390\/ijms222111864.","DOI":"10.3390\/ijms222111864"},{"key":"2625_CR210","doi-asserted-by":"publisher","unstructured":"Pach\u00f3n Olmos V, Poll\u00e1n M, Fern\u00e1ndez de Larrea-Baz N, et al. Determinants of adherence to world cancer research fund\/American Institute for Cancer Research Recommendations in Women with Breast Cancer. Cancers (Basel). 2025;17(4). https:\/\/doi.org\/10.3390\/cancers17040708.","DOI":"10.3390\/cancers17040708"},{"issue":"1","key":"2625_CR211","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-016-0280-0","volume":"17","author":"V Bellizzi","year":"2016","unstructured":"Bellizzi V, Cupisti A, Locatelli F, et al. Low-protein diets for chronic kidney disease patients: the Italian experience. BMC Nephrol. 2016;17(1):77. https:\/\/doi.org\/10.1186\/s12882-016-0280-0.","journal-title":"BMC Nephrol"},{"issue":"6","key":"2625_CR212","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1053\/j.ajkd.2022.11.014","volume":"81","author":"VK Sullivan","year":"2023","unstructured":"Sullivan VK, Rebholz CM. Nutritional epidemiology and dietary assessment for patients with kidney disease: a primer. Am J Kidney Dis. 2023;81(6):717\u201327. https:\/\/doi.org\/10.1053\/j.ajkd.2022.11.014.","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"2625_CR213","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13783","volume":"25","author":"D Wang","year":"2024","unstructured":"Wang D, Benito PJ, Rubio-Arias J, Ramos-Campo DJ, Rojo-Tirado MA. Exploring factors of adherence to weight loss interventions in population with overweight\/obesity: an umbrella review. Obes Rev. 2024;25(9):e13783. https:\/\/doi.org\/10.1111\/obr.13783.","journal-title":"Obes Rev"},{"key":"2625_CR214","doi-asserted-by":"publisher","DOI":"10.2196\/53006","volume":"12","author":"T Sun","year":"2024","unstructured":"Sun T, Xu X, Ding Z, et al. Development of a health behavioral digital intervention for patients with hypertension based on an intelligent health promotion system and WeChat: randomized controlled trial. JMIR Mhealth Uhealth. 2024;12:e53006. https:\/\/doi.org\/10.2196\/53006.","journal-title":"JMIR Mhealth Uhealth"},{"key":"2625_CR215","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuad012","author":"PT van Leeuwen","year":"2023","unstructured":"van Leeuwen PT, Brul S, Zhang J, Wortel MT. Synthetic microbial communities (SynComs) of the human gut: design, assembly, and applications. FEMS Microbiol Rev. 2023. https:\/\/doi.org\/10.1093\/femsre\/fuad012.","journal-title":"FEMS Microbiol Rev"},{"issue":"1","key":"2625_CR216","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/apt.16148","volume":"53","author":"C Marcella","year":"2021","unstructured":"Marcella C, Cui B, Kelly CR, Ianiro G, Cammarota G, Zhang F. Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020. Aliment Pharmacol Ther. 2021;53(1):33\u201342. https:\/\/doi.org\/10.1111\/apt.16148.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"2625_CR217","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-68526-0","volume":"14","author":"X Hu","year":"2024","unstructured":"Hu X, Ge J, Wen Y. Computational study of novel natural agonists targeting farnesoid X receptor. Sci Rep. 2024;14(1):17597. https:\/\/doi.org\/10.1038\/s41598-024-68526-0.","journal-title":"Sci Rep"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02625-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02625-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02625-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:54:43Z","timestamp":1770832483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-025-02625-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":217,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2625"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02625-x","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}